Status:
UNKNOWN
Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea
Lead Sponsor:
The University of Hong Kong
Conditions:
Obstructive Sleep Apnea
Cardiovascular Diseases
Eligibility:
MALE
18-65 years
Brief Summary
Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular ...
Detailed Description
1. Primary outcome: Incidence of cardiometabolic diseases in subjects with OSA over 9 years. 2. Secondary outcomes: Effects of CPAP treatment on cardiometabolic conditions
Eligibility Criteria
Inclusion
- From previous cohort for reassessment.
Exclusion
- Unstable medical conditions
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2015
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT01475682
Start Date
November 1 2011
End Date
May 1 2015
Last Update
July 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong